These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18715174)

  • 1. Myoclonus associated with high-dose parenteral methadone.
    Ito S; Liao S
    J Palliat Med; 2008 Jul; 11(6):838-41. PubMed ID: 18715174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone for cancer pain: a case report.
    Nixon AJ
    Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone-Induced Neurotoxicity in Advanced Cancer: A Case Report.
    Hoff AM; Hartwig KN; Rosielle DA
    J Palliat Med; 2017 Sep; 20(9):1042-1044. PubMed ID: 28488910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer.
    Latuga NM; Wahler RG
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
    Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
    J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of methadone in the management of pain in cancer patients.
    Bruera E; Neumann CM
    Oncology (Williston Park); 1999 Sep; 13(9):1275-82; discussion 1285-8, 1291. PubMed ID: 10509323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone-induced myoclonus in advanced cancer.
    Sarhill N; Davis MP; Walsh D; Nouneh C
    Am J Hosp Palliat Care; 2001; 18(1):51-3. PubMed ID: 11406880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from parenteral to oral methadone.
    González-Barboteo J; Porta-Sales J; Sánchez D; Tuca A; Gómez-Batiste X
    J Pain Palliat Care Pharmacother; 2008; 22(3):200-5. PubMed ID: 19042849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
    Leng G; Finnegan MJ
    Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The successful use of parenteral methadone in a patient with a prolonged QTc interval.
    Sekine R; Obbens EA; Coyle N; Inturrisi CE
    J Pain Symptom Manage; 2007 Nov; 34(5):566-9. PubMed ID: 17616330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual methadone for the management of cancer-related breakthrough pain: a pilot study.
    Hagen NA; Fisher K; Stiles C
    J Palliat Med; 2007 Apr; 10(2):331-7. PubMed ID: 17472503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
    Finkel JC; Pestieau SR; Quezado ZM
    J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dantrolene treatment of opioid-induced myoclonus.
    Mercadante S
    Anesth Analg; 1995 Dec; 81(6):1307-8. PubMed ID: 7486124
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.